|
|
| | Fmoc-L-Thr(β-D-GalNAc(Ac)3)-OH Basic information |
| Product Name: | Fmoc-L-Thr(β-D-GalNAc(Ac)3)-OH | | Synonyms: | Fmoc-L-Thr(2-D-GalNAc(Ac)3)-OH;Fmoc-Thr(GalNAc(Ac)3-b-D)-OH;Fmoc-Thr(GalNAc(Ac)?-β-D)-OH;L-Threonine, N-[(9H-fluoren-9-ylmethoxy)carbonyl]-O-[3,4,6-tri-O-acetyl-2-(acetylamino)-2-deoxy-β-D-galactopyranosyl]-;Fmoc-Thr(b-D-GalNAc(Ac)3)-OH;2-Acetamido-3,4,6-tri-O-acetyl-2-deoxy-β-D-galactopyranosyl-Fmoc threonine;RMA-483;Fmoc-Thr(GalNAc(Ac)3-β-D)-OH | | CAS: | 133575-43-6 | | MF: | C33H38N2O13 | | MW: | 670.66 | | EINECS: | | | Product Categories: | | | Mol File: | 133575-43-6.mol |  |
| | Fmoc-L-Thr(β-D-GalNAc(Ac)3)-OH Chemical Properties |
| Boiling point | 857.1±65.0 °C(Predicted) | | density | 1.38±0.1 g/cm3(Predicted) | | pka | 3.32±0.10(Predicted) | | Sequence | Fmoc-{Thr(GalNAc(Ac)3-β-D)}-OH |
| | Fmoc-L-Thr(β-D-GalNAc(Ac)3)-OH Usage And Synthesis |
| Uses | Fmoc-Thr(GalNAc(Ac)3-β-D)-OH inhibits cancer cell growth, through targeting intricate cancer-specific pathways while simultaneously strengthening immunologic response[1]. | | References | [1] Levi S Simpson, et al. Regulation of chemokine recognition by site-specific tyrosine sulfation of receptor peptides. Chem Biol. 2009 Feb 27;16(2):153-61. DOI:10.1016/j.chembiol.2008.12.007 |
| | Fmoc-L-Thr(β-D-GalNAc(Ac)3)-OH Preparation Products And Raw materials |
|